Regenerative Medical Technology Group's receivables is $110K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Regenerative Medical Technology Group (RMTG) currently reports a receivables of $110K as of June 2026. That compares with $37K in the prior-year period — up 200.6% year over year. Use the charts on this page to explore Regenerative Medical Technology Group's receivables history and peer comparisons.
Regenerative Medical Technology Group's receivables increased from $37K to $110K — a 200.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Regenerative Medical Technology Group reported $110K in receivables as of June 2026. That compares with $37K in the prior-year period — up 200.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $110K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Regenerative Medical Technology Group, and consider following RMTG for alerts when major investors trade the stock.
Regenerative Medical Technology Group is classified in the Healthcare sector. On receivables, it currently shows $110K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RMTG with unrelated industries.